Ally Bridge Leads in Targeted Cancer Therapies
21 Jul 2026
US$ 20.00
Hong Kong & US-based Ally Bridge Group has led the US$315 m series D funding round of AdvanCell Pty Ltd ......
Tag
Healthcare
Related Publications
Subscribers’ Weekly for the week ending 24 July 2026...
Listen to Southeast Asia Investments (Subscribers' Weekly 24 Jul 2026)...
Connect With Us
We love to share Asia PE insights and news from time to time. Drop us your email address if you like to hear from us.
Rest assured that your email address will not be shared, as we hate spams as much as you do.